TTK Healthcare Live BSE/NSE | TTK Healthcare Fundamenta data | TTK Healthcare Balance sheet | TTK Healthcare Quarterly Results | TTK Healthcare Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

765.65
121.96
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

661.72
0.55%
2.82

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.58
4.47
3.79

EBITDA CAGR (%)

10 Years
5 Years
3 Years

2.78
-6.90
-7.83

PAT CAGR (%)

10 Years
5 Years
3 Years

-1.76
-11.48
-12.15

P:E (Median)

8 Years
5 Years
3 Years

37.31
37.08
40.55

P:BV (Average)

8 Years
5 Years
3 Years

2.58
2.58
2.58

EV:EBITDA (Average)

8 Years
5 Years
3 Years

16.12
15.94
16.77

Quarterly Results

Standalone Figures in Rs. Crores

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 159.67 164.85 -3.14% 116.40 178.59 -34.82% 136.52 139.61 -2.21% 165.81 149.05 11.24%
Expenses 150.62 156.44 -3.72% 117.08 170.14 -31.19% 133.79 129.80 3.07% 157.11 138.60 13.35%
EBITDA 9.05 8.42 7.48% -0.68 8.45 - 2.72 9.81 -72.27% 8.70 10.45 -16.75%
EBIDTM 5.67% 5.11% -0.59% 4.73% 2.00% 7.02% 5.25% 7.01%
Other Income 2.15 1.95 10.26% 1.92 1.86 3.23% 2.74 2.28 20.18% 2.22 1.74 27.59%
Interest 0.59 0.75 -21.33% 0.63 0.68 -7.35% 0.93 0.69 34.78% 0.91 0.70 30.00%
Depreciation 3.43 3.58 -4.19% 3.54 3.54 0.00% 3.60 4.08 -11.76% 3.66 3.47 5.48%
PBT 15.28 6.04 152.98% -2.92 6.09 - 0.94 7.32 -87.16% 6.36 8.02 -20.70%
Tax -15.53 2.26 - -0.52 2.45 - 0.52 2.36 -77.97% 1.88 3.14 -40.13%
PAT 30.81 3.78 715.08% -2.40 3.64 - 0.42 4.95 -91.52% 4.48 4.88 -8.20%
PATM 19.30% 2.29% -2.06% 2.04% 0.31% 3.55% 2.70% 3.28%
EPS 21.85 2.68 715.30% -1.70 2.58 - 0.30 3.51 -91.45% 3.18 3.46 -8.09%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 578.40 645.77 627.88 577.55 527.81 518.87 482.93 416.18 382.30 353.74 310.92 Net Sales Growth -8.50% 2.85% 8.71% 9.42% 1.72% 7.44% 16.04% 8.86% 8.07% 13.77% Cost Of Goods Sold 228.15 260.02 262.59 241.59 243.44 229.27 219.45 194.45 189.59 186.19 162.57 Gross Profit 350.25 385.75 365.29 335.95 284.37 289.59 263.48 221.72 192.71 167.55 148.35 GP Margin 60.55% 59.73% 58.18% 58.17% 53.88% 55.81% 54.56% 53.28% 50.41% 47.37% 47.71% Total Expenditure 558.60 617.47 578.33 535.00 489.32 478.40 453.38 396.48 362.15 329.98 289.40 Power & Fuel Cost - 15.00 13.56 12.57 7.36 6.54 5.62 7.02 5.72 3.37 2.66 % Of Sales - 2.32% 2.16% 2.18% 1.39% 1.26% 1.16% 1.69% 1.50% 0.95% 0.86% Employee Cost - 143.94 130.70 120.12 87.99 81.42 72.28 60.66 52.95 43.56 36.82 % Of Sales - 22.29% 20.82% 20.80% 16.67% 15.69% 14.97% 14.58% 13.85% 12.31% 11.84% Manufacturing Exp. - 17.80 14.85 13.76 11.60 9.61 5.35 4.58 4.02 3.57 2.72 % Of Sales - 2.76% 2.37% 2.38% 2.20% 1.85% 1.11% 1.10% 1.05% 1.01% 0.87% General & Admin Exp. - 58.55 54.37 53.47 50.20 51.02 48.17 42.78 37.04 30.84 27.00 % Of Sales - 9.07% 8.66% 9.26% 9.51% 9.83% 9.97% 10.28% 9.69% 8.72% 8.68% Selling & Distn. Exp. - 114.58 94.84 87.32 83.91 96.35 97.94 82.19 69.12 57.16 51.62 % Of Sales - 17.74% 15.10% 15.12% 15.90% 18.57% 20.28% 19.75% 18.08% 16.16% 16.60% Miscellaneous Exp. - 7.59 7.42 6.16 4.81 4.18 4.57 4.79 3.72 5.29 51.62 % Of Sales - 1.18% 1.18% 1.07% 0.91% 0.81% 0.95% 1.15% 0.97% 1.50% 1.93% EBITDA 19.79 28.30 49.55 42.55 38.49 40.47 29.55 19.70 20.15 23.76 21.52 EBITDA Margin 3.42% 4.38% 7.89% 7.37% 7.29% 7.80% 6.12% 4.73% 5.27% 6.72% 6.92% Other Income 9.03 8.78 7.75 7.57 5.73 5.59 6.57 6.12 6.74 4.70 4.41 Interest 3.06 3.27 3.38 4.73 3.11 3.33 3.64 2.99 2.54 2.56 1.81 Depreciation 14.23 14.38 14.67 15.24 11.92 7.21 6.14 3.17 2.72 2.36 1.97 PBT 19.66 19.42 39.26 30.15 29.18 35.53 26.33 19.67 21.62 23.55 22.14 Tax -13.65 7.11 14.89 11.98 10.44 12.86 10.18 7.28 7.42 7.92 7.42 Tax Rate -69.43% 36.61% 37.93% 39.73% 35.78% 36.19% 38.66% 37.01% 34.32% 33.63% 33.51% PAT 33.31 12.32 24.37 18.17 18.74 22.67 16.16 12.39 14.20 15.63 14.72 PAT before Minority Interest 33.31 12.32 24.37 18.17 18.74 22.67 16.16 12.39 14.20 15.63 14.72 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.76% 1.91% 3.88% 3.15% 3.55% 4.37% 3.35% 2.98% 3.71% 4.42% 4.73% PAT Growth 93.10% -49.45% 34.12% -3.04% -17.34% 40.28% 30.43% -12.75% -9.15% 6.18% Unadjusted EPS 23.62 8.74 17.28 12.89 13.29 16.08 11.46 8.79 10.07 11.09 10.44

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

578.40

645.77

627.88

577.55

527.81

518.87

482.93

416.18

382.30

353.74

310.92

Net Sales Growth

-8.50%

2.85%

8.71%

9.42%

1.72%

7.44%

16.04%

8.86%

8.07%

13.77%

Cost Of Goods Sold

228.15

260.02

262.59

241.59

243.44

229.27

219.45

194.45

189.59

186.19

162.57

Gross Profit

350.25

385.75

365.29

335.95

284.37

289.59

263.48

221.72

192.71

167.55

148.35

GP Margin

60.55%

59.73%

58.18%

58.17%

53.88%

55.81%

54.56%

53.28%

50.41%

47.37%

47.71%

Total Expenditure

558.60

617.47

578.33

535.00

489.32

478.40

453.38

396.48

362.15

329.98

289.40

Power & Fuel Cost

15.00

13.56

12.57

7.36

6.54

5.62

7.02

5.72

3.37

2.66

% Of Sales

2.32%

2.16%

2.18%

1.39%

1.26%

1.16%

1.69%

1.50%

0.95%

0.86%

Employee Cost

143.94

130.70

120.12

87.99

81.42

72.28

60.66

52.95

43.56

36.82

% Of Sales

22.29%

20.82%

20.80%

16.67%

15.69%

14.97%

14.58%

13.85%

12.31%

11.84%

Manufacturing Exp.

17.80

14.85

13.76

11.60

9.61

5.35

4.58

4.02

3.57

2.72

% Of Sales

2.76%

2.37%

2.38%

2.20%

1.85%

1.11%

1.10%

1.05%

1.01%

0.87%

General & Admin Exp.

58.55

54.37

53.47

50.20

51.02

48.17

42.78

37.04

30.84

27.00

% Of Sales

9.07%

8.66%

9.26%

9.51%

9.83%

9.97%

10.28%

9.69%

8.72%

8.68%

Selling & Distn. Exp.

114.58

94.84

87.32

83.91

96.35

97.94

82.19

69.12

57.16

51.62

% Of Sales

17.74%

15.10%

15.12%

15.90%

18.57%

20.28%

19.75%

18.08%

16.16%

16.60%

Miscellaneous Exp.

7.59

7.42

6.16

4.81

4.18

4.57

4.79

3.72

5.29

51.62

% Of Sales

1.18%

1.07%

0.91%

0.81%

0.95%

1.15%

0.97%

1.50%

1.93%

EBITDA

19.79

28.30

49.55

42.55

38.49

40.47

29.55

19.70

20.15

23.76

21.52

EBITDA Margin

3.42%

4.38%

7.89%

7.37%

7.29%

7.80%

6.12%

4.73%

5.27%

6.72%

6.92%

Other Income

9.03

8.78

7.75

7.57

5.73

5.59

6.57

6.12

6.74

4.70

4.41

Interest

3.06

3.27

3.38

4.73

3.11

3.33

3.64

2.99

2.54

2.56

1.81

Depreciation

14.23

14.38

14.67

15.24

11.92

7.21

6.14

3.17

2.72

2.36

1.97

PBT

19.66

19.42

39.26

30.15

29.18

35.53

26.33

19.67

21.62

23.55

22.14

Tax

-13.65

7.11

14.89

11.98

10.44

12.86

10.18

7.28

7.42

7.92

7.42

Tax Rate

-69.43%

36.61%

37.93%

39.73%

35.78%

36.19%

38.66%

37.01%

34.32%

33.63%

33.51%

PAT

33.31

12.32

24.37

18.17

18.74

22.67

16.16

12.39

14.20

15.63

14.72

PAT before Minority Interest

33.31

12.32

24.37

18.17

18.74

22.67

16.16

12.39

14.20

15.63

14.72

Minority Interest

0.00

PAT Margin

5.76%

1.91%

3.88%

3.15%

3.55%

4.37%

3.35%

2.98%

3.71%

4.42%

4.73%

PAT Growth

93.10%

-49.45%

34.12%

-3.04%

-17.34%

40.28%

30.43%

-12.75%

-9.15%

6.18%

Unadjusted EPS

23.62

8.74

17.28

12.89

13.29

16.08

11.46

8.79

10.07

11.09

10.44

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 248.99 251.43 232.97 157.47 136.21 118.27 106.93 98.22 87.70 75.73 Share Capital 14.13 14.13 14.13 7.77 7.77 7.77 7.77 7.77 7.77 7.77 Total Reserves 234.86 237.30 218.84 149.70 128.45 110.50 99.16 90.46 79.94 67.97 Non-Current Liabilities 6.55 2.43 2.24 7.73 16.37 27.87 27.23 11.26 10.35 9.45 Secured Loans 0.00 0.33 0.66 0.87 1.06 15.98 15.87 0.58 0.47 0.62 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 7.75 6.97 6.13 4.45 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 171.50 157.08 167.52 119.71 149.94 129.06 105.78 99.87 94.32 107.70 Trade Payables 86.51 72.72 86.33 66.71 33.37 30.07 29.95 28.56 35.81 31.61 Other Current Liabilities 54.48 51.95 31.50 30.23 89.93 72.47 58.95 46.11 37.34 36.22 Short Term Borrowings 28.13 27.88 46.39 22.00 21.95 22.30 13.24 21.55 17.55 12.41 Short Term Provisions 2.39 4.53 3.31 0.77 4.68 4.22 3.64 3.64 3.62 27.47 Total Liabilities 427.04 410.94 402.73 284.91 302.52 275.20 239.94 209.35 192.37 192.88 Net Block 88.65 97.57 109.53 99.22 106.22 51.88 53.67 43.44 33.35 32.61 Gross Block 148.81 144.20 140.91 110.99 146.21 86.38 82.89 70.21 58.46 55.72 Accumulated Depreciation 60.03 45.71 31.38 11.76 39.99 34.50 29.22 26.77 25.11 23.11 Non Current Assets 129.34 139.22 147.13 118.35 118.96 109.10 77.07 54.98 46.32 44.72 Capital Work in Progress 8.77 1.54 0.79 0.25 0.85 45.70 1.97 0.31 5.94 4.78 Non Current Investment 8.75 13.05 9.26 8.83 0.00 0.00 0.00 0.00 0.00 6.00 Long Term Loans & Adv. 23.17 27.07 27.55 10.05 11.89 11.52 21.43 11.23 7.03 1.32 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 297.70 271.72 255.61 166.56 183.56 166.10 162.87 154.37 146.06 148.17 Current Investments 0.00 0.00 0.00 0.00 10.13 0.13 0.13 0.77 6.77 0.84 Inventories 71.64 55.31 52.90 43.63 41.45 37.38 33.95 27.10 32.68 26.83 Sundry Debtors 76.77 80.25 55.34 34.26 46.62 44.41 38.30 35.10 37.36 32.48 Cash & Bank 132.06 125.62 135.88 82.03 77.16 77.30 84.06 83.76 61.90 60.81 Other Current Assets 17.23 4.72 3.92 2.47 8.19 6.87 6.43 7.64 7.35 27.21 Short Term Loans & Adv. 11.70 5.83 7.58 4.17 7.44 6.12 5.68 6.85 6.56 26.48 Net Current Assets 126.20 114.64 88.09 46.85 33.62 37.04 57.09 54.50 51.74 40.47 Total Assets 427.04 410.94 402.74 284.91 302.52 275.20 239.94 209.35 192.38 192.89

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

248.99

251.43

232.97

157.47

136.21

118.27

106.93

98.22

87.70

75.73

Share Capital

14.13

7.77

Total Reserves

234.86

237.30

218.84

149.70

128.45

110.50

99.16

90.46

79.94

67.97

Non-Current Liabilities

6.55

2.43

2.24

7.73

16.37

27.87

27.23

11.26

10.35

9.45

Secured Loans

0.00

0.33

0.66

0.87

1.06

15.98

15.87

0.58

0.47

0.62

Unsecured Loans

0.00

Long Term Provisions

7.75

6.97

6.13

4.45

0.00

Current Liabilities

171.50

157.08

167.52

119.71

149.94

129.06

105.78

99.87

94.32

107.70

Trade Payables

86.51

72.72

86.33

66.71

33.37

30.07

29.95

28.56

35.81

31.61

Other Current Liabilities

54.48

51.95

31.50

30.23

89.93

72.47

58.95

46.11

37.34

36.22

Short Term Borrowings

28.13

27.88

46.39

22.00

21.95

22.30

13.24

21.55

17.55

12.41

Short Term Provisions

2.39

4.53

3.31

0.77

4.68

4.22

3.64

3.62

27.47

Total Liabilities

427.04

410.94

402.73

284.91

302.52

275.20

239.94

209.35

192.37

192.88

Net Block

88.65

97.57

109.53

99.22

106.22

51.88

53.67

43.44

33.35

32.61

Gross Block

148.81

144.20

140.91

110.99

146.21

86.38

82.89

70.21

58.46

55.72

Accumulated Depreciation

60.03

45.71

31.38

11.76

39.99

34.50

29.22

26.77

25.11

23.11

Non Current Assets

129.34

139.22

147.13

118.35

118.96

109.10

77.07

54.98

46.32

44.72

Capital Work in Progress

8.77

1.54

0.79

0.25

0.85

45.70

1.97

0.31

5.94

4.78

Non Current Investment

8.75

13.05

9.26

8.83

0.00

6.00

Long Term Loans & Adv.

23.17

27.07

27.55

10.05

11.89

11.52

21.43

11.23

7.03

1.32

Other Non Current Assets

0.00

Current Assets

297.70

271.72

255.61

166.56

183.56

166.10

162.87

154.37

146.06

148.17

Current Investments

0.00

10.13

0.13

0.77

6.77

0.84

Inventories

71.64

55.31

52.90

43.63

41.45

37.38

33.95

27.10

32.68

26.83

Sundry Debtors

76.77

80.25

55.34

34.26

46.62

44.41

38.30

35.10

37.36

32.48

Cash & Bank

132.06

125.62

135.88

82.03

77.16

77.30

84.06

83.76

61.90

60.81

Other Current Assets

17.23

4.72

3.92

2.47

8.19

6.87

6.43

7.64

7.35

27.21

Short Term Loans & Adv.

11.70

5.83

7.58

4.17

7.44

6.12

5.68

6.85

6.56

26.48

Net Current Assets

126.20

114.64

88.09

46.85

33.62

37.04

57.09

54.50

51.74

40.47

Total Assets

427.04

410.94

402.74

284.91

302.52

275.20

239.94

209.35

192.38

192.89

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 19.84 17.31 25.30 17.81 37.35 39.44 12.66 24.35 6.21 25.37 PBT 19.42 39.26 30.15 29.18 35.53 26.33 19.67 21.62 23.55 22.14 Adjustment 7.18 10.11 13.16 9.52 10.41 10.12 6.16 4.44 4.86 3.06 Changes in Working Capital 4.03 -18.77 -7.35 -12.75 3.58 15.50 -9.26 6.29 -7.71 8.09 Cash after chg. in Working capital 30.63 30.59 35.96 25.94 49.53 51.95 16.57 32.35 20.69 33.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -10.79 -13.29 -10.66 -8.13 -12.17 -12.51 -3.91 -8.01 -14.48 -7.92 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -13.30 9.65 -22.56 5.26 -26.73 -49.14 -14.60 -0.52 -4.27 -7.14 Net Fixed Assets -11.84 -4.04 -30.46 35.82 -14.98 -47.22 -14.34 -6.12 -3.90 -8.29 Net Investments 4.30 -3.79 -0.43 1.30 -10.00 0.00 0.64 6.00 0.07 1.31 Others -5.76 17.48 8.33 -31.86 -1.75 -1.92 -0.90 -0.40 -0.44 -0.16 Cash from Financing Activity -10.17 -30.73 -7.20 -22.94 -10.79 2.91 2.19 -2.04 -0.94 -6.76 Net Cash Inflow / Outflow -3.63 -3.77 -4.46 0.13 -0.16 -6.79 0.25 21.79 1.00 11.47 Opening Cash & Equivalents 11.15 14.92 19.04 18.91 76.81 83.60 83.35 61.56 60.56 49.34 Closing Cash & Equivalent 7.53 11.15 14.92 19.04 76.65 76.81 83.60 83.35 61.56 60.81

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

19.84

17.31

25.30

17.81

37.35

39.44

12.66

24.35

6.21

25.37

PBT

19.42

39.26

30.15

29.18

35.53

26.33

19.67

21.62

23.55

22.14

Adjustment

7.18

10.11

13.16

9.52

10.41

10.12

6.16

4.44

4.86

3.06

Changes in Working Capital

4.03

-18.77

-7.35

-12.75

3.58

15.50

-9.26

6.29

-7.71

8.09

Cash after chg. in Working capital

30.63

30.59

35.96

25.94

49.53

51.95

16.57

32.35

20.69

33.29

Interest Paid

0.00

Tax Paid

-10.79

-13.29

-10.66

-8.13

-12.17

-12.51

-3.91

-8.01

-14.48

-7.92

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

-13.30

9.65

-22.56

5.26

-26.73

-49.14

-14.60

-0.52

-4.27

-7.14

Net Fixed Assets

-11.84

-4.04

-30.46

35.82

-14.98

-47.22

-14.34

-6.12

-3.90

-8.29

Net Investments

4.30

-3.79

-0.43

1.30

-10.00

0.00

0.64

6.00

0.07

1.31

Others

-5.76

17.48

8.33

-31.86

-1.75

-1.92

-0.90

-0.40

-0.44

-0.16

Cash from Financing Activity

-10.17

-30.73

-7.20

-22.94

-10.79

2.91

2.19

-2.04

-0.94

-6.76

Net Cash Inflow / Outflow

-3.63

-3.77

-4.46

0.13

-0.16

-6.79

0.25

21.79

1.00

11.47

Opening Cash & Equivalents

11.15

14.92

19.04

18.91

76.81

83.60

83.35

61.56

60.56

49.34

Closing Cash & Equivalent

7.53

11.15

14.92

19.04

76.65

76.81

83.60

83.35

61.56

60.81

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 173.09 174.81 161.75 197.09 169.71 146.54 131.87 120.60 106.99 91.51 ROA 2.94% 5.99% 5.28% 6.38% 7.85% 6.27% 5.51% 7.07% 8.11% 8.48% ROE 5.01% 10.25% 9.52% 13.16% 18.46% 14.94% 12.64% 16.07% 20.28% 22.47% ROCE 8.28% 15.46% 15.42% 18.63% 23.85% 20.71% 18.12% 22.23% 28.12% 30.21% Fixed Asset Turnover 4.41 4.40 4.59 4.10 4.46 5.71 5.44 5.94 6.20 6.12 Receivable days 44.37 39.41 28.31 27.96 32.00 31.24 32.18 34.59 36.03 32.27 Inventory Days 35.88 31.45 30.50 29.42 27.71 26.94 26.76 28.54 30.70 29.14 Payable days 50.12 53.93 57.34 40.77 26.81 26.75 29.79 36.84 40.63 59.12 Cash Conversion Cycle 30.13 16.93 1.47 16.61 32.91 31.43 29.15 26.29 26.10 2.29 Total Debt/Equity 0.12 0.12 0.21 0.15 0.29 0.37 0.31 0.24 0.22 0.19 Interest Cover 6.94 12.62 7.37 10.37 11.68 8.23 7.58 9.50 10.20 13.24

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

173.09

174.81

161.75

197.09

169.71

146.54

131.87

120.60

106.99

91.51

ROA

2.94%

5.99%

5.28%

6.38%

7.85%

6.27%

5.51%

7.07%

8.11%

8.48%

ROE

5.01%

10.25%

9.52%

13.16%

18.46%

14.94%

12.64%

16.07%

20.28%

22.47%

ROCE

8.28%

15.46%

15.42%

18.63%

23.85%

20.71%

18.12%

22.23%

28.12%

30.21%

Fixed Asset Turnover

4.41

4.40

4.59

4.10

4.46

5.71

5.44

5.94

6.20

6.12

Receivable days

44.37

39.41

28.31

27.96

32.00

31.24

32.18

34.59

36.03

32.27

Inventory Days

35.88

31.45

30.50

29.42

27.71

26.94

26.76

28.54

30.70

29.14

Payable days

50.12

53.93

57.34

40.77

26.81

26.75

29.79

36.84

40.63

59.12

Cash Conversion Cycle

30.13

16.93

1.47

16.61

32.91

31.43

29.15

26.29

26.10

2.29

Total Debt/Equity

0.12

0.21

0.15

0.29

0.37

0.31

0.24

0.22

0.19

Interest Cover

6.94

12.62

7.37

10.37

11.68

8.23

7.58

9.50

10.20

13.24

TTK Healthcare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 507747 | NSE: TTKHLTCARE

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

TTK Healthcare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 507747 | NSE: TTKHLTCARE

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update